Psyence Biomedical

PBMNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$23.267 M

$6.10 -6.44%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

2,293,277

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Psyence Biomedical lists more than one class of stock. Company figures above cover all classes combined.

PBMWW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#389Universe PharmaceuticalsUPC$23.4M
#390Korsana BiosciencesKRSA$23.4M
#391Psyence BiomedicalPBM$23.3M
#392Cocrystal PharmaCOCP$22.9M
#393Atossa TherapeuticsATOS$22.6M

What if Psyence Biomedical were worth as much as…

Open the what-if tool →

Gold $30.2T

$7,926,421

Per share 1,299,413× higher

Bitcoin $1.74T

$456,608.62

Per share 74,854× higher

Nvidia $5.52T

$1,446,065

Per share 237,060× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Psyence Biomedical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.